Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01572974 · ClinicalTrials.gov registry record

Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease

A clinical trial, sponsored by Midwest Biomedical Research Foundation.

Terminated
Registry status
89
Enrollment target

NCT01572974 is a clinical trial that was terminated before completion, run by Midwest Biomedical Research Foundation. The registered enrollment target is 89 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01572974 was terminated before completion, sponsored by Midwest Biomedical Research Foundation.

TERMINATED
Registry status
89 participants
Enrollment target

Study Summary

To Compare the overall quality of life of patients with no Barrett's esophagus , non-dysplastic Barrett's Esophagus (NDBE), Barrett's esophagus with low grade dysplasia (LGD), and Barrett's esophagus with high grade dysplasia (HGD). We also Compare the overall quality of life of Barrett's esophagus patients with severe gastroesophageal reflux disease (GERD) symptoms to those with no GERD symptoms

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2010-01
Est. Completion 2017-12

What the Registry Record Tells You About NCT01572974

The ClinicalTrials.gov registry entry for NCT01572974 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Biomedical Research Foundation, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01572974 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01572974 about?

NCT01572974 is a clinical study titled "Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease". To Compare the overall quality of life of patients with no Barrett's esophagus , non-dysplastic Barrett's Esophagus (NDBE), Barrett's esophagus with low grade dysplasia (LGD), and Barrett's esophagus with high grade dysplasia (HGD). We also Compare the overall quality of life of Barrett's esophagus ...

What is the current status of trial NCT01572974?

This trial is currently terminated. The enrollment target is 89 participants. The study started on 2010-01. Estimated completion is 2017-12.

Who is sponsoring clinical trial NCT01572974?

This trial is sponsored by Midwest Biomedical Research Foundation, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.